Shiga toxins, glycosphingolipid diversity, and endothelial cell injury
- 1 January 2009
- journal article
- review article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 101 (02) , 252-264
Abstract
Shiga toxin (Stx)-producing Escherichia coli (STEC) cause an enteric illness that results in a spectrum of outcomes ranging from asymptomatic carriage to uncomplicated diarrhea, bloody diarrhea, and the postdiarrheal haemolytic uremic syndrome (HUS), which leads to renal and other organ microvascular thrombosis. Binding of Stx to the glycosphingolipid (GSL) globotriaosylceramide (Gb3Cer/CD77) on endothelial cells followed by receptor-mediated endocytosis is the linchpin in STEC-mediated disease. Only GSLs that associate strongly with lipid rafts appear to carry Stxs retrogradely from the plasma membrane through the Golgi apparatus to the endoplasmic reticulum where they are translocated to the cytosol and exert their toxic function. Thus, the biophysical features of the lipid moiety of GSL receptors may influence its incorporation into certain membrane domains and thereby affect toxin destination. Consequently, a detailed structural analysis of Stx-binding GSLs is required to illuminate the molecular causes that may underlie the different Stx susceptibilities of endothelial cells derived from various vascular beds. Solid phase overlay binding assays of thin-layer chromatography (TLC)-separated GSL preparations employing specific antibodies and/or Stxs in conjunction with anti-Stx-antibodies are commonly used for the identification of Stx-binding GSLs. Such GSL-profiling combined with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) represents a convenient strategy to structurally characterize Stx-receptors from any biological sources such as primary cells, cell lines, or organs. This approach may be helpful to gain insights into Stx-induced impairment of target cells that is suggested to originate at least partly from the structural heterogeneity of the cellular ligands of Stxs.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft
This publication has 96 references indexed in Scilit:
- Shiga toxin induces tubular membrane invaginations for its uptake into cellsNature, 2007
- Chemical validation of molecular mimicry: interaction of cholera toxin with Campylobacter lipooligosaccharidesGlycoconjugate Journal, 2007
- Retrograde transport from endosomes to the trans-Golgi networkNature Reviews Molecular Cell Biology, 2006
- Receptors, rafts, and microvesicles in thrombosis and inflammationJournal of Thrombosis and Haemostasis, 2005
- Shiga toxins and apoptosisFEMS Microbiology Letters, 2003
- Molecular Basis for Up‐Regulation by Inflammatory Cytokines of Shiga Toxin 1 Cytotoxicity and Globotriaosylceramide ExpressionThe Journal of Infectious Diseases, 2002
- Human Microvascular Endothelial Cells Are Strongly Sensitive to Shiga ToxinsBiochemical and Biophysical Research Communications, 1998
- Affinity purification of Shiga-like toxin I and Shiga-like toxin IIJournal of Microbiological Methods, 1998
- Purification and Characterization of a Phage-encoded Cytotoxin from an Escherichia coli O111 Strain Associated with Hemolytic-uremic SyndromeZentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A: Medical Microbiology, Infectious Diseases, Virology, Parasitology, 1988
- Globotriosyl ceramide is specifically recognized by the escherichia coli verocytotoxin 2Biochemical and Biophysical Research Communications, 1988